2 Safe S&P 500 Healthcare Dividend Stocks Boomers Can Buy and Hold Forever24/7 Wall Street • 11/02/26
4 Blue-Chip Dividend Stocks That Kept Raising Payouts Through 2008 and 202024/7 Wall Street • 11/01/26
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusiness Wire • 11/01/26
Johnson & Johnson Just Took $7 Billion in Charges and Still Raised Its Outlook. Here's What That Tells Investors.The Motley Fool • 10/31/26
JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Zacks Investment Research • 10/30/26
4 Dividend Kings With 50-Plus Years of Payout Increases for Retirement Income24/7 Wall Street • 10/30/26
Merck Rises 5% as Earnings Beat Lifts Profit Outlook; Eli Lilly Climbs 7%, Johnson & Johnson Edges Higher24/7 Wall Street • 10/29/26
Johnson & Johnson (JNJ) Is Considered a Good Investment by Brokers: Is That True?Zacks Investment Research • 10/29/26
Medtronic Has Raised Its Dividend for 49 Years. These 2 Rivals Have Even Longer Streaks24/7 Wall Street • 10/27/26
4 Arthritis Drug Stocks Investors Should Monitor for Growth PotentialZacks Investment Research • 10/27/26